JSK Therapeutics, Inc. — Form D

JSK Therapeutics, Inc. of SANDY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-12. The offering totals $1.0M, of which $963K was reported sold. Industry: Other Technology.

Offering

• Filed: 2017-12-12
• Form: D
• Accession: 0001724999-17-000001
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $963K
• Remaining: $50K
• Investors: 10
• Date of first sale: 2017-11-27
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-300466

Issuer

• Name: JSK Therapeutics, Inc.
• CIK: 0001724999
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 9758 CERVANTES CIRCLE, SANDY, UT, 84092
• Phone: 801-971-6678

Officers, directors & promoters (7)

More

• CIK 1724999 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search